UNSPSC 51283208: Spiramycin

This classification denotes a macrolide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 71ODY0V87H. European Medicines Agency schedules Spiramycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04526MIG. Spiramycin generally arises in the molecular formula C43H74N2O14.

The term SPIRAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, no. 12, 1959, list 3.) SPIRAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule spiramycin under HS 29419000 and SITC 54139. As of Q4 2014, SPIRAMYCIN remains the US FDA Preferred Term for this commodity. Spiramycin bears US NLM identifiers UMLS ID C0037962 and NCI Concept Code C839.

UNSPSC 51283208 Spiramycin, a Commodity code, identifies individual pharmaceutical products for state and local procurement, though recent activity under this specific code shows little direct alignment with the spiramycin product itself. State and local health departments and county governments use codes in this family to procure prescription antibiotics and related pharmaceutical supplies through competitive bidding and cooperative purchasing vehicles such as MMCAP Infuse. The work typically involves sourcing specific drug formulations—measured by unit count, package size, shelf life, and delivery frequency—to support emergency preparedness, public health stockpiles, and community health programs. Procurement is generally time-sensitive and driven by regulatory or epidemiological need rather than ongoing operational demand.

Recent activity under related pharmaceutical-procurement codes shows issuing bodies concentrated in state health departments and county health authorities across the Southeast and Midwest. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 via IFB for Doxycycline Hyclate and Ciprofloxacin Hydrochloride over a 12-month initial term with two renewal options. Seminole County, Florida, posted an IFB in June 2026 (response due July 26, 2026) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, including all shipping costs in the bid. The source provides no open solicitations explicitly tagged to UNSPSC 51283208 for spiramycin itself; vendors pursuing activity under this specific code should verify current posting activity and geographic availability before committing pursuit resources.